ELT: new horizons in theory and application

por Haase, Christoph, Orlova, Natalia, Head, Joel Cameron
Publicado 2015

High-performance method for identification of super enhancers from ChIP-Seq data with configurable cloud virtual machines

por Orlova, Natalia N., Bogatova, Olga V., Orlov, Alexey V.
Publicado 2020

Removing independent noise in systems neuroscience data using DeepInterpolation

por Lecoq, Jérôme, Oliver, Michael, Siegle, Joshua H., Orlova, Natalia, Ledochowitsch, Peter, Koch, Christof
Publicado 2021

Efficacy and safety of the combined metabolic medication, containing inosine, nicotinamide, riboflavin and succinic acid, for the treatment of diabetic neuropathy: a multicenter ra...

por Kharitonova, Tatiana, Shvarts, Yury G, Verbovoy, Andrey F, Orlova, Natalia S, Puzyreva, Valentina P, Strokov, Igor A
Publicado 2022

The replication initiator of the cholera pathogen's second chromosome shows structural similarity to plasmid initiators

por Orlova, Natalia, Gerding, Matthew, Ivashkiv, Olha, Olinares, Paul Dominic B., Chait, Brian T., Waldor, Matthew K., Jeruzalmi, David
Publicado 2017

Drawing Parallels between SARS, MERS, and COVID-19: A Comparative Overview of Epidemiology, Pathogenesis, and Pathological Features

por Pustake, Manas, Giri, Purushottam, Ganiyani, Mohammad Arfat, Mumtaz, Kahkashan, Deshmukh, Krishna, Saju, Michael, Nunez, Judith Vasquez, Orlova, Natalia, Das, Arghadip
Publicado 2023

Synergistic suppression of t(8;21)-positive leukemia cell growth by combining oridonin and MAPK1/ERK2 inhibitors

por Spirin, Pavel, Lebedev, Timofey, Orlova, Natalia, Morozov, Alexey, Poymenova, Nadezhda, Dmitriev, Sergey E., Buzdin, Anton, Stocking, Carol, Kovalchuk, Olga, Prassolov, Vladimir
Publicado 2017

Experimental Validation and Prediction of Super-Enhancers: Advances and Challenges

por Kravchuk, Ekaterina V., Ashniev, German A., Gladkova, Marina G., Orlov, Alexey V., Vasileva, Anastasiia V., Boldyreva, Anna V., Burenin, Alexandr G., Skirda, Artemiy M., Nikitin, Petr I., Orlova, Natalia N.
Publicado 2023

CRISPR-CasX is an RNA-dominated enzyme active for human genome editing

por Liu, Jun-Jie, Orlova, Natalia, Oakes, Benjamin L., Ma, Enbo, Spinner, Hannah B., Baney, Katherine L.M., Chuck, Jonathan, Tan, Dan, Knott, Gavin J., Harrington, Lucas B., Al-Shayeb, Basem, Wagner, Alexander, Brötzmann, Julian, Staahl, Brett T., Talyor, Kian L., Desmarais, John, Nogales, Eva, Doudna, Jennifer A.
Publicado 2019